NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
May 30 04:00PM ET
64.04
Dollar change
+1.26
Percentage change
2.01
%
IndexS&P 500 P/E15.30 EPS (ttm)4.19 Insider Own0.15% Shs Outstand1.27B Perf Week6.34%
Market Cap81.01B Forward P/E9.07 EPS next Y7.06 Insider Trans-66.27% Shs Float1.26B Perf Month-4.00%
Income5.28B PEG1.11 EPS next Q1.45 Inst Own86.71% Short Float1.26% Perf Quarter-2.56%
Sales378.85B P/S0.21 EPS this Y13.02% Inst Trans3.14% Short Ratio1.55 Perf Half Y6.59%
Book/sh60.96 P/B1.05 EPS next Y15.24% ROA2.09% Short Interest15.90M Perf Year19.41%
Cash/sh10.05 P/C6.37 EPS next 5Y13.79% ROE7.00% 52W Range43.56 - 72.51 Perf YTD42.66%
Dividend Est.2.32 (3.63%) P/FCF13.64 EPS past 5Y-6.37% ROI3.51% 52W High-11.68% Beta0.55
Dividend TTM2.66 (4.15%) Quick Ratio0.63 Sales past 5Y7.79% Gross Margin14.02% 52W Low47.02% ATR (14)2.00
Dividend Ex-DateApr 22, 2025 Current Ratio0.82 EPS Y/Y TTM-26.54% Oper. Margin3.05% RSI (14)50.96 Volatility0.71% 2.41%
Employees300000 Debt/Eq1.06 Sales Y/Y TTM4.84% Profit Margin1.39% Recom1.69 Target Price79.36
Option/ShortYes / Yes LT Debt/Eq0.96 EPS Q/Q60.22% Payout72.76% Rel Volume1.29 Prev Close62.78
Sales Surprise0.97% EPS Surprise32.15% Sales Q/Q6.96% EarningsMay 01 BMO Avg Volume10.28M Price64.04
SMA200.77% SMA50-2.54% SMA2007.63% Trades Volume13,305,714 Change2.01%
Date Action Analyst Rating Change Price Target Change
Feb-13-25Upgrade Leerink Partners Market Perform → Outperform $55 → $75
Feb-12-25Upgrade Cantor Fitzgerald Neutral → Overweight
Jan-30-25Upgrade Edward Jones Hold → Buy
Dec-03-24Upgrade Deutsche Bank Hold → Buy $66
Nov-18-24Upgrade Wells Fargo Equal Weight → Overweight $60 → $66
Oct-10-24Upgrade Barclays Equal Weight → Overweight $63 → $82
Oct-04-24Upgrade TD Cowen Hold → Buy $59 → $85
May-30-24Initiated Robert W. Baird Neutral $61
May-07-24Downgrade TD Cowen Buy → Hold $99 → $59
May-02-24Downgrade UBS Buy → Neutral $85 → $60
May-30-25 10:14AM
09:32AM
09:31AM
May-29-25 10:08AM
10:06AM
09:29AM Loading…
09:29AM
09:05AM
07:10AM
May-28-25 03:00PM
11:50AM
11:47AM
09:14AM
05:49AM
May-26-25 12:42PM
11:40AM
09:40AM Loading…
09:40AM
May-23-25 04:03PM
10:46AM
10:36AM
06:52AM
May-22-25 04:55PM
04:45PM
04:43PM
01:34PM
11:39AM
10:59AM
10:37AM
09:54AM
09:30AM
06:28AM
05:14PM Loading…
May-21-25 05:14PM
10:48AM
09:44AM
09:00AM
07:21AM
07:17AM
05:30AM
May-20-25 09:22AM
05:30AM
May-19-25 10:12AM
07:02AM
May-18-25 06:00PM
May-17-25 07:00AM
May-16-25 04:12PM
10:22AM
10:12AM
09:59AM
09:55AM
08:00AM
07:59AM
07:30AM
04:55AM
May-15-25 05:09PM
02:24PM
10:51AM
10:08AM
08:36AM
07:45AM
May-14-25 06:44PM
03:00PM
11:16AM
11:16AM
09:32AM
09:32AM
07:46AM
05:57AM
05:30AM
May-13-25 12:15PM
10:37AM
09:26AM
May-12-25 05:36PM
04:54PM
04:53PM
02:00PM
01:04PM
08:55AM
May-11-25 05:23PM
May-09-25 12:03PM
12:01PM
12:00PM
11:40AM
09:45AM
09:30AM
09:15AM
06:20AM
12:35AM
May-08-25 04:47PM
12:10PM
12:06PM
11:53AM
06:20AM
May-07-25 02:00PM
01:21PM
01:09PM
12:50PM
12:30PM
12:28PM
12:27PM
11:05AM
10:59AM
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ROBBINS LARRYDirectorMay 02 '25Sale67.862,276,068154,444,7589,670,731May 06 04:15 PM
ROBBINS LARRYDirectorMay 05 '25Sale67.411,323,93289,249,9458,346,799May 06 04:15 PM
ROBBINS LARRYDirectorMay 06 '25Sale66.67150,00010,000,7108,196,799May 06 04:15 PM
Shah Prem SEVP and Group PresidentMar 17 '25Option Exercise62.2184652,63043,190Mar 18 04:51 PM
Clark James DavidSVP, Cont & Chief Acct OfficerMar 05 '25Option Exercise62.217,513467,38415,907Mar 07 04:56 PM
Clark James DavidSVP, Cont & Chief Acct OfficerMar 05 '25Sale66.357,513498,4888,394Mar 07 04:56 PM
Clark James DavidOfficerMar 05 '25Proposed Sale66.357,513498,489Mar 05 05:25 PM
Mahoney Michael FDirectorFeb 18 '25Buy66.7030,0002,001,00039,356Feb 19 12:35 PM